Cystic Fibrosis and Cosmetic Surgery: Lung Function, CFTR Modulators, Low BMI, Breast Surgery, CF-Related Diabetes, and Anesthesia

She is 31 and, for the first time in her life, she has gained weight on purpose without fighting for every pound. Three years ago her CF team started her on a triple-combination modulator, and the changes were the kind her doctors still describe as remarkable: fewer hospital admissions, a lung function number that climbed back toward where it was in her teens, an appetite that stayed. Now she wants to talk about two things she never expected to care about. She would like a modest breast augmentation, because years of being underweight left her with very little breast tissue, and she has noticed a stubborn pocket of lower belly fat that did not exist when she weighed 98 pounds. She also has an implanted port scar on her upper chest that she would like revised. When the surgeon's intake form asks about lung disease, she writes "CF, stable." That is accurate, and it is nowhere near enough.

Cystic fibrosis is one of those conditions where the patient usually knows more than the cosmetic surgeon does, and where the risk is not one big danger but a dozen small ones that compound. The lungs are the obvious concern. Less obvious are the pancreas, the liver, the bones, the sinuses, the blood sugar, the vitamins that govern bleeding and healing, the drug interactions with modulators, the infection control rules that CF patients live by, and the twice-daily airway clearance that does not stop because there is a new incision across the chest. None of this means an adult with CF cannot have cosmetic surgery. It means the right operation, done in the right place, at the right moment in the disease, with the CF team in the loop from the start.

Cystic fibrosis and cosmetic surgery: why the conversation is new

The short answer: cystic fibrosis is an inherited disease in which a faulty protein called CFTR makes mucus thick and sticky in the lungs, sinuses, pancreas, and other organs, and because modulator drugs have extended life and improved health for many people with CF, a growing number of adults are now asking about elective cosmetic procedures that would have been out of the question a generation ago.

CF is caused by mutations in both copies of the CFTR gene, which makes a channel that moves chloride and water across the surface of cells. When the channel does not work, secretions dry out and thicken. In the lungs, mucus traps bacteria and sets off a cycle of infection and inflammation that slowly scars the airways, a process called bronchiectasis. In the pancreas, thick secretions block the ducts that carry digestive enzymes, so most people with CF cannot absorb fat properly without enzyme capsules at every meal. The sinuses fill with polyps. The sweat glands lose too much salt, which is why the classic diagnostic test measures chloride in sweat, and why all newborns in the United States are now screened for CF.

The Cystic Fibrosis Foundation estimates that close to 40,000 people in the United States live with CF, and its patient registry shows that more than half are now adults. That shift has been building for decades through better antibiotics, nutrition, and airway clearance, but the larger jump came with CFTR modulators, drugs that help the faulty protein fold, reach the cell surface, and open. The FDA approved the triple combination of elexacaftor, tezacaftor, and ivacaftor in 2019, and has since expanded it to young children and approved a newer once-daily combination. For people with eligible mutations, which covers most but not all of the CF population, modulators have produced large improvements in lung function, fewer flares, and weight gain that many patients had never managed before.

That is the backdrop for a new kind of consultation. Some adults with CF want help with the visible marks of a lifetime of treatment: port and feeding tube scars, chest tube scars, a nose shaped by repeated sinus surgery. Some want what any thirty-something might want: a breast augmentation, a nose that breathes better and looks different, liposuction for fat that arrived along with better health. Some have had a lung transplant and are asking about the scar across the chest. Each of these is a reasonable request. Each also lands on a body that carries more risk than the intake form suggests, and the piece on how anesthesia choice shapes the operative plan explains why those risks need to be on the table weeks before the operation, not on the morning of it.

Before the consultation: lung function, flares, bacteria, and the CF team

The short answer: the safest window for elective surgery in CF is a period of stable lung function, at least several weeks after the last pulmonary exacerbation or course of IV antibiotics, with the CF center's pulmonologist actively involved, and a patient who is in the middle of a decline, a flare, or a transplant evaluation should postpone rather than push through.

The CF center comes first. Most adults with CF are followed by an accredited CF care center with a pulmonologist, dietitian, respiratory therapist, and social worker. That team knows the patient's lung function trend, their usual bacteria, their antibiotic history, and how they tolerated past anesthesia far better than any cosmetic practice can learn in one consultation. A surgeon who plans elective surgery on a CF patient without talking to that team is guessing. A patient should expect, and if necessary insist, that the surgeon and anesthesiologist get a letter or a phone call from the CF pulmonologist before a date is set.

Lung function and its trend. CF lung disease is usually tracked with FEV1, the amount of air a person can blow out in one second, expressed as a percentage of what would be predicted for their age, height, and sex. A single number is less useful than the direction it has been moving. A patient whose FEV1 has been stable or improving on a modulator is in a very different position from one whose numbers have been sliding for a year. Severely reduced lung function makes general anesthesia and the first days after surgery riskier, raises the chance of needing a breathing tube longer than planned, and should push the conversation toward smaller procedures or none at all. The piece on COPD and cosmetic surgery covers the same physiology from a different disease: abdominal operations, tight binders, pain that discourages deep breaths, and opioids that slow breathing all push damaged lungs in the wrong direction.

Flares and IV antibiotics. A pulmonary exacerbation in CF, often treated with two or more weeks of intravenous antibiotics, leaves the airways inflamed and full of secretions for a while after the patient feels better. Elective surgery should wait until the patient is back to baseline lung function and has been stable for a period the CF team considers safe. Some centers like to schedule a "tune-up" of airway clearance, and occasionally antibiotics, before a planned operation so the lungs go in as clean as possible. A patient who notices more coughing, more mucus, a change in color, a drop in home spirometry, or a new fever in the week before surgery should call the surgeon's office. A deposit is not a medical reason to operate.

The bacteria matter. Many adults with CF carry chronic lung infections with organisms such as Pseudomonas aeruginosa, MRSA, Burkholderia cepacia complex, or nontuberculous mycobacteria. That history changes which antibiotics the surgeon uses around the operation, a topic covered in the piece on antibiotics after cosmetic surgery. It also changes how the practice should handle the patient. The CF Foundation's infection prevention guidance recommends that people with CF keep at least six feet away from one another and avoid sharing spaces, because they can pass these organisms to each other. A thoughtful practice schedules a CF patient as the first case of the day or in a dedicated room, does not seat two CF patients in the same waiting area, and cleans equipment between them. If a practice has never heard of this, that is useful information.

Hemoptysis and pneumothorax. Coughing up blood and collapsed lung are both more common in advanced CF. A recent episode of either is a reason to postpone, and a history of a collapsed lung matters for anesthesia, for air travel after surgery, and for the positive pressure ventilation used under general anesthesia. The piece on Marfan syndrome and cosmetic surgery discusses why a prior pneumothorax changes planning around breast surgery in particular.

Transplant recipients. Adults who have had a lung transplant for CF no longer have CF in the new lungs, but they still have it everywhere else, and they now take lifelong immunosuppressive drugs that slow healing and raise infection risk. Cosmetic surgery after transplant is possible, typically once the transplant team considers the patient stable, and always with that team's input. The piece on chronic kidney disease, dialysis, and transplant medications covers how immunosuppressants affect wound healing and which painkillers are off the table.

Modulators, enzymes, vitamins, and blood sugar: the medication picture

The short answer: CFTR modulators should usually continue through surgery but interact with several common drugs, pancreatic enzymes and fat-soluble vitamins affect healing and bleeding, CF-related diabetes needs the same careful blood sugar plan as any other diabetes, and the full medication list belongs in front of both the surgeon and the CF team.

Modulators and drug interactions. Elexacaftor, tezacaftor, and ivacaftor, like the newer combination, are broken down by a liver enzyme system called CYP3A. Drugs that strongly block that system, including some antifungals and certain antibiotics, can push modulator levels up, and drugs that strongly speed it up, including rifampin and some anti-seizure medications, can make modulators stop working. Several drugs used around surgery pass through the same system. The modulator label also advises avoiding grapefruit, and recommends monitoring liver enzymes. None of this is a reason to stop a modulator for surgery. Most CF teams want patients to keep taking it, timed with fat-containing food as prescribed, because stopping can lead to a rebound in symptoms. It is a reason for the anesthesiologist and the pharmacist to see the list.

Enzymes and nutrition. Most people with CF take pancreatic enzyme capsules with every meal and snack. Around surgery, fasting rules interrupt that rhythm, and the first meals afterward need enzymes as usual. Malnutrition has long been one of the central problems in CF, and while modulators have changed weight for many patients, protein stores, zinc, and overall reserve still matter for wound healing. The piece on pre-op nutrition optimization covers what surgeons look for, and the piece on celiac disease and cosmetic surgery explains how malabsorption from a different cause shows up in iron, vitamin D, and healing.

Vitamins A, D, E, and K. Because fat absorption is impaired, people with CF are prone to low levels of the fat-soluble vitamins and usually take a CF-specific supplement. Vitamin K matters directly to surgery, because it is needed to make clotting factors; a deficient patient can bleed more than expected, and a simple blood test can check clotting before the operation. Vitamin A supports skin healing. Vitamin D matters for bone, which leads to the next problem.

Bones. CF-related bone disease, with low bone density and a higher fracture risk, is common in adults, driven by poor absorption, inflammation, delayed puberty, steroid courses, and low body weight. Chronic coughing can even crack ribs. Patients with low bone density should mention it, especially before any procedure involving the chest wall or facial bones; the piece on osteoporosis and cosmetic surgery covers the medications involved.

CF-related diabetes. As people with CF live longer, CF-related diabetes has become one of the most common complications in adults; the CF Foundation describes it as affecting a substantial share of adults, with the proportion rising with age. It is not the same as type 1 or type 2 diabetes, but the surgical concerns overlap: high blood sugar around surgery raises the risk of infection and poor wound healing. A patient on insulin needs a plan for the fasting period, the day of surgery, and the first days afterward, made with whoever manages their diabetes. A surgeon will reasonably want recent blood sugar control documented before an elective operation.

The liver. Some adults with CF have CF-related liver disease, ranging from mild enzyme elevations to cirrhosis with an enlarged spleen and low platelets. That changes how the body handles anesthetic drugs and acetaminophen, and how much the patient might bleed. The piece on fatty liver disease and cosmetic surgery covers the liver questions a surgeon should ask.

Salt and fluids. People with CF lose more salt in sweat than other people and can become dehydrated and salt-depleted quickly, especially in heat. Long preoperative fasting, a warm recovery room, compression garments, and nausea can combine into a patient who is drier than anyone realizes. CF teams often encourage generous fluids and added salt, and the anesthesia team should know that baseline.

"With cystic fibrosis, the risk is rarely one dramatic thing. It is a modulator interaction, a low vitamin K, a blood sugar running high, and an airway clearance session skipped because it hurts, all on the same day."

Procedure by procedure: breast surgery, body contouring, rhinoplasty, and scar revision

The short answer: breast augmentation and body contouring are possible in stable adults with CF, but implant placement, the length of the operation, and the effect on breathing and airway clearance all need to be weighed, rhinoplasty often makes the most sense combined with sinus care, and scar revision under local anesthesia is among the lowest-risk requests a CF patient can make.

Breast augmentation. Many women with CF have little breast tissue, from years of low body weight and sometimes delayed puberty, and a modest augmentation is one of the more common cosmetic requests. Three CF-specific issues shape the plan. The first is placement. Implants placed under the chest muscle, as discussed in the piece on pre-pectoral breast implant placement, tend to hurt more in the first week, and the piece on pain after breast augmentation describes the chest tightness that makes deep breaths and coughing unpleasant. For a patient whose lungs depend on deep breaths and productive coughing, that matters. Placement over the muscle has its own trade-offs in a very thin patient, including more visible implant edges, so this is a real discussion rather than a default. The second is size. A thin chest wall with little soft tissue cover does not tolerate large implants well, and the piece on how surgeons decide implant size explains why tissue measurements, not a target cup, should drive the choice. The third is coughing. Forceful, repeated coughing in the early days can raise the risk of bleeding into the implant pocket and can strain incisions. That does not mean a CF patient should suppress coughing, which would be far worse for the lungs. It means bracing the chest with a pillow, and a clear plan from the surgeon about what is normal.

Fat grafting to the breast. Fat transfer requires spare fat to harvest, which many people with CF simply do not have, and the piece on fat transfer breast augmentation explains why the volume gained is usually modest. For patients who have gained weight on modulators it may become an option, with the caveat that weight changes after surgery change grafted fat too.

Liposuction and tummy tucks. Some adults on modulators gain weight quickly, and some of that weight settles around the abdomen. Before treating it surgically, a patient and surgeon should be confident that weight has stabilized, since the piece on whether fat comes back after liposuction makes clear that later gains still show up. Small-volume liposuction under local or light sedation carries far less pulmonary risk than a long operation under general anesthesia. A full tummy tuck with muscle tightening, as with COPD, places real demands on breathing in the first days, because a tight abdominal wall limits the diaphragm and pain discourages deep breaths. A mini tummy tuck or a more limited operation may make more sense. Years of chronic coughing also raise the odds of abdominal wall hernias, which a surgeon should look for; the piece on umbilical hernia repair with a tummy tuck explains why a persistent cough is a leading reason hernia repairs fail. Patients with gastrostomy tube scars on the abdomen should mention them, as the piece on old abdominal surgery scars and a tummy tuck discusses how prior incisions affect skin blood supply.

Rhinoplasty and the sinuses. Chronic sinus disease and nasal polyps are nearly universal in CF, and many adults have had one or more sinus operations. A patient who wants a cosmetic nose change is often also a patient who cannot breathe well through their nose, and the most sensible plan may combine cosmetic work with functional and sinus surgery performed by a surgeon, or a pair of surgeons, comfortable with both. The piece on chronic sinusitis, nasal polyps, and rhinoplasty covers how combined procedures work, and the piece on functional rhinoplasty explains the breathing side. Packing and swelling that block the nose matter more for someone whose sinuses are already chronically infected, and the CF team may want to adjust sinus rinses or antibiotics around the operation.

Scar revision. Port scars on the upper chest, PICC line marks on the arm, chest tube scars on the side, and gastrostomy scars on the abdomen are among the most common reasons adults with CF see a plastic surgeon. Many of these can be revised under local anesthesia in an office setting, which avoids most of the pulmonary risk of general anesthesia entirely. The piece on cosmetic surgery after chemotherapy covers port scar removal and timing in detail, with one CF-specific caveat: a patient who still uses an implanted port for regular IV antibiotics should not have it removed for cosmetic reasons without the CF team agreeing that it is no longer needed. The piece on scar care after plastic surgery covers what helps a revised scar settle.

Anesthesia and the first week: airway clearance, pain, opioids, and the gut

The short answer: the operations that go well in CF are short, use regional or local anesthesia where possible, happen in a facility that can manage breathing problems, and are followed by a recovery plan that keeps airway clearance going, limits opioids, and watches closely for constipation and intestinal blockage.

Choosing the anesthesia. Local anesthesia, regional nerve blocks, and light sedation all avoid much of what makes general anesthesia hard on CF lungs. When general anesthesia is needed, the team will plan airway clearance immediately before and after, may suction secretions during the case, and will try to keep the operation as short as possible. Long combined procedures, the six-hour mommy makeover, are exactly the wrong shape for CF; staging into shorter operations is usually the wiser choice. The anesthesiologist will also want to know about any history of collapsed lung, coughing up blood, or difficult intubation.

Where the operation happens. A small office suite is appropriate for local procedures. Anything under general anesthesia in a patient with significant lung disease belongs in an accredited facility with the equipment and staff to handle a breathing emergency, and often in a hospital where a CF team can be reached and an overnight stay is an option rather than an emergency. The piece on outpatient facility accreditation explains what accreditation does and does not guarantee, and the piece on hospital privileges for cosmetic surgeons explains why it matters whether the surgeon can admit a patient if things change.

Airway clearance after surgery. People with CF usually clear mucus once or twice a day with some combination of breathing techniques, oscillating handheld devices, chest percussion, or a high-frequency chest wall oscillation vest. A fresh breast or abdominal incision can make the usual routine painful or unsafe, and a vest strapped over new breast implants is a different proposition from a vest on an unoperated chest. The time to work this out is before surgery, with the CF respiratory therapist and the surgeon together: which techniques are allowed, which pressures, how soon the vest can return, and what alternatives fill the gap. Skipping airway clearance for a week to protect the incision is how a cosmetic operation turns into a hospital admission for a lung infection.

Pain without heavy opioids. Opioids suppress coughing, slow breathing, and cause constipation, all of which are worse in CF. Nerve blocks, long-acting local anesthetic in the wound, acetaminophen, and other non-opioid approaches reduce how much opioid a patient needs. Anti-inflammatory painkillers are a decision for the CF team, because some patients take high-dose ibuprofen as part of their lung treatment while others have kidney concerns from years of certain IV antibiotics.

The gut. People with CF are prone to a condition called distal intestinal obstruction syndrome, in which thick intestinal contents block the bowel. Fasting, dehydration, opioids, and missed enzyme doses can all trigger it. Constipation after surgery is a nuisance for most people; in CF it can become a blockage. The piece on hemorrhoids and opioid constipation after surgery covers the general problem, and CF patients should leave with a specific bowel plan from their CF team, plus clear instructions to call about abdominal swelling, cramping, vomiting, or no bowel movement.

Clots and walking. Getting up and walking early helps the lungs and lowers the risk of blood clots, which the piece on blood clots after plastic surgery covers in depth. People with CF who have long-term central lines or ports have their own clot risks, and clot prevention plans should account for that and for any liver-related bleeding tendency.

Warning signs. In the first week, a patient with CF should call the surgeon and the CF team for a fever, more coughing or mucus than usual, coughing up blood, sudden chest pain or shortness of breath, a drop in home spirometry readings, blood sugars running high, or abdominal swelling with no bowel movement. For someone who is weighing whether to go ahead at all, a second consultation with a surgeon who has operated on CF patients before is worth the time.

The honest summary

Cystic fibrosis is no longer a reason to assume cosmetic surgery is off the table. Modulators have given many adults with CF stable lungs, healthier weights, and ordinary aesthetic wishes, and a modest breast augmentation, small-volume liposuction, a combined functional and cosmetic nose operation, or a port scar revision can all be reasonable in the right patient. What CF does is change the definition of the right patient and the right plan. Lung function should be stable and trending in the right direction, the last flare should be well behind the patient, and the CF pulmonologist should be part of the decision rather than a name on a form. Modulators, enzymes, vitamins, insulin, and usual bacteria all belong in the anesthesia plan. Shorter operations under lighter anesthesia, in a facility that can manage a breathing problem, beat long combined procedures. And the recovery plan has to include airway clearance from day one, a clear approach to coughing, minimal opioids, and a watchful eye on the gut. A surgeon who welcomes the call to the CF center is the right surgeon. A surgeon who treats "CF, stable" as a checked box is not.